Market closedNon-fractional

Eyenovia/EYEN

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Eyenovia

Eyenovia Inc is a clinical stage ophthalmic company developing a pipeline of therapeutics based on its propriety array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Opejet, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance and topical delivery success for ophthalmic eye treatments. Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies which target new indications or new combinations.

Ticker

EYEN

Sector

Healthcare

Trading on

NASDAQ

Industry

Pharmaceuticals

Headquarters

New York, United States

Employees

57

Eyenovia Metrics

BasicAdvanced
$74M
Market cap
-
P/E ratio
-$0.75
EPS
1.71
Beta
-
Dividend rate
$74M
1.71
0.878
0.52
434.569
915.081
-11.64%
-68.07%
-368.02%
5,297.03
27.9
-11.78
-1.549
0.64%
-87.00%
-4.25%

What the Analysts think about Eyenovia

Analyst Ratings

Majority rating from 4 analysts.
Buy

Eyenovia Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
0.00% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$0
NaN%
Net income
-$11M
37.97%
Profit margin
0.00%
NaN%

Eyenovia Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 31.93%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.16
-$0.18
-$0.18
-$0.23
-
Expected
-$0.18
-$0.18
-$0.18
-$0.17
-$0.15
Surprise
-8.57%
0.00%
2.86%
31.93%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Eyenovia stock?

Eyenovia (EYEN) has a market cap of $74M as of July 15, 2024.

What is the P/E ratio for Eyenovia stock?

The price to earnings (P/E) ratio for Eyenovia (EYEN) stock is 0 as of July 15, 2024.

Does Eyenovia stock pay dividends?

No, Eyenovia (EYEN) stock does not pay dividends to its shareholders as of July 15, 2024.

When is the next Eyenovia dividend payment date?

Eyenovia (EYEN) stock does not pay dividends to its shareholders.

What is the beta indicator for Eyenovia?

Eyenovia (EYEN) has a beta rating of 1.71. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy or sell Eyenovia stock

Buy or sell Eyenovia stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing